Can midodrine cause tachycardia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 31, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Midodrine and Tachycardia

Midodrine does not typically cause tachycardia; rather, it is more commonly associated with bradycardia due to its reflex parasympathetic stimulation effect. 1

Mechanism of Action and Cardiovascular Effects

  • Midodrine is an alpha-1 adrenergic receptor agonist that produces arteriolar constriction and venoconstriction, increasing peripheral vascular resistance and improving central blood volume in patients with orthostatic hypotension 2
  • The medication is primarily used for treating symptomatic orthostatic hypotension, particularly in neurogenic orthostatic hypotension and intradialytic hypotension in hemodialysis patients 2
  • Midodrine is associated with reflex bradycardia rather than tachycardia, as the increased blood pressure from alpha-1 stimulation triggers a compensatory parasympathetic response 1
  • In clinical studies, midodrine has been shown to decrease heart rate in patients with postural tachycardia syndrome (POTS), not increase it 3, 4

Cardiovascular Side Effects

  • The primary cardiovascular side effects of midodrine include:
    • Bradycardia (slowing of heart rate) due to reflex parasympathetic stimulation 1
    • Supine hypertension, which can occur in up to 25% of patients 2
  • In overdose situations, midodrine can cause severe hypertension with reflex bradycardia, as demonstrated in a case report of a patient who ingested up to 350 mg 5

Clinical Applications in Tachycardia Conditions

  • Midodrine has actually been used therapeutically to reduce heart rate in conditions associated with tachycardia:
    • In neuropathic postural tachycardia syndrome (POTS), midodrine has been shown to decrease standing heart rate by increasing calf vascular resistance and decreasing calf blood flow 3
    • Studies have demonstrated midodrine's effectiveness in suppressing tachycardia in POTS patients, with heart rates decreasing from 114 bpm to approximately 93 bpm 4
    • Midodrine has also been used successfully in treating refractory neurocardiogenic syncope, a condition often associated with tachycardia followed by bradycardia 6

Monitoring and Precautions

  • When using midodrine, healthcare providers should:
    • Monitor for bradycardia, especially when used concomitantly with other negative chronotropic agents (beta-blockers, digoxin, non-dihydropyridine calcium channel blockers) 1
    • Avoid concomitant use with other α-adrenergic agents (ephedrine, pseudoephedrine, phenylpropanolamine) as this may aggravate supine hypertension 1
    • Use with caution in patients with congestive heart failure as it may be poorly tolerated 1
    • Withhold midodrine if the patient develops supine systolic hypertension or bradycardia 1

Conclusion

Midodrine is more likely to cause bradycardia than tachycardia due to its mechanism of action. In fact, it is sometimes used therapeutically to reduce heart rate in conditions like POTS. If a patient experiences tachycardia while taking midodrine, clinicians should consider other causes or potential drug interactions rather than attributing the tachycardia directly to midodrine.

References

Guideline

Guidelines for Midodrine Therapy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Mechanism of Action and Clinical Applications of Midodrine

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Treatment of postural tachycardia syndrome: a comparison of octreotide and midodrine.

Clinical autonomic research : official journal of the Clinical Autonomic Research Society, 2006

Research

Severe Hypertension and Bradycardia Secondary to Midodrine Overdose.

Journal of medical toxicology : official journal of the American College of Medical Toxicology, 2017

Research

Preliminary observations on the use of midodrine hydrochloride in the treatment of refractory neurocardiogenic syncope.

Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing, 1999

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.